A simple, rapid, specific and highly sensitive eco-friendly spectrofluorimetric method has been developed for the quantification of praziquantel. A linear relationship was found between fluorescence intensity and praziquantel concentration in the range of 1-20 µg/mL in water at emission wavelength of 286 nm after excitation wavelength at 263 nm with a good correlation coefficient (0.999). The proposed method was validated according to ICH guidelines and statistical analysis of the results revealed high accuracy and good precision with the percentage RSD values less than 2. The detection and quantification limits were found to be 0.27 and 0.81 µg/mL, respectively.
Introduction
Chemically, praziquantel is 2-cyclohexanecarbonyl-1H,2H,3H,4H,6H,7H,11bHpiperazino [2,1-a] isoquinolin-4-one ( Fig.1) . It comes under the category of anthelmintic, used for the treatment of schistosome and many cestode infestations.
Schistosomiasis is a parasitic disease caused by worms that penetrate the skin of people through water. Praziquantel is the only drug for treatment of schistosomiasis.
Praziquantel is effective and safe. Work is ongoing to expand the treatment with praziquantel in young children as well [1, 2] .
The extended literature survey revealed that few analytical methods (using HPLC and HPLC-MS) reported for estimation of praziquantel [3] [4] [5] [6] [7] . Till now, one spectrofluorimetric method was reported for praziquantel quantification in blood-plasma and urine. As the method was complicated because drug chemical derivatization with dansyl chloride, which involved various solvents with many extraction procedures. keeping above points into consideration we attempted this work with an objective to develop a simple method for praziquantel quantification in pharmaceutical dosage forms in presence of degradation products and in-vitro dissolution samples. Spectrofluorimetry has implicit a foremost role in drug analysis because of its greater sensitivity, furthermore specific than absorption spectrophotometry. Fluorimetry involve in the estimation of drug solution at two wavelengths, excitation and emission in fluorescence; an emission spectrum is acquired by scanning the emission monochromator at determined emission wavelengths (λem), at a particular excitation wavelength (λex) [8] [9] [10] [11] [12] [13] .
Nowadays, dissolution tests are routinely used in the pharmaceutical industry in a wide variety of applications, to identify which sort of formulation will produce the best results in the clinic, to release products to the market, to verify batch-to-batch reproducibility [14, 15] . International conference on harmonization (ICH) Q1A guidelines suggested procedures to carry out stress degradation studies to ensure high quality, safety and efficacy of the pharmaceutical product during its storage. Forced degradation (FD) study/ Stress testing is a process in which the natural degradation rate of a pharmaceutical product is increased by the application of an additional stress.
It is an important part of the drug development process as it provides knowledge about u n c o r r e c t e d p r o o f the degradation chemistry of drug compounds to develop stability-indicating analytical methods and characterization of degradation products [16] .
Keeping all these points into consideration, the present work was attempted with the objective to develop and validate the simple spectrofluorimetric method for quantification of praziquantel in pharmaceutical dosage forms. The application of proposed method to study the in-vitro dissolution profiles of praziquantel and further extended to stress degradation studies of praziquantel, degradation kinetics also calculated.
MATERIALS AND METHODS

Chemicals and reagents
All chemicals and reagents were of analytical grade. Praziquantel (99.50 %) pure was obtained as gift samples from Taj Pharmaceutical Ltd., Mumbai, India. Tablets Pharmacopeia [17] .
Instrumentation
The Shimadzu (Japan) RF-5301 PC Spectrofluoro photometer used for the measurement of fluorescence intensity of selected drug, which is equipped with 150watt Xenon arc lamp, 1 cm non-fluorescent quartz cell was used, connected to RFPC software. The instrument was operated both at low and high sensitivity with excitation and emission slit width set at 5 nm. Analytical balance (Shimadzu AUX 220, Japan), dissolution apparatus (Electro Lab, TDT-08L, India), pH meter (Elico), hot air oven and UV-cabinet (Bio-Technics, India) were used for the study. 
Preparation of standard stock solutions
Construction of calibration graph
The standard stock solution of praziquantel (100 µg/mL) was used to prepare set of diluted standard solutions of various concentrations (1-20 µg/mL) prepared by pipetting appropriate volumes (0.1, 0.5, 1, 1.5 ,2 mL) of stock solution into 10.0 mL volumetric flasks and adjusting the volume to mark with distilled water. These solutions were scanned in Spectro fluorimeter at λex of 263 nm.
Determination of praziquantel in tablet dosage form (assay)
Twenty tablets of marketed formulation (Zenticide®), each containing 600 mg of praziquantel were taken and accurately weighed. Average weight was determined and 
RESULTS AND DISCUSSION
Selection of wavelength
To attain sensitive and specific spectrofluorimetric method for quantification of praziquantel, several solvent systems were investigated such as methanol, di methyl sulfoxide (DMSO), ethanol, di methyl formamide (DMF) and glacial acetic acid.
Fluorescence intensity was higher in methanol-water (1:9) than the other solvent systems ( Fig.2 ) and exhibits native fluorescence at emission wave length 286 nm after excitation at 263 nm in the presence of polycyclic aromatic system like pyrazino and isoquinolin rings with more π electrons (Fig.3 ). Hence methanol-water (1:9) was selected as solvent for quantification, forced degradation studies and in-vitro dissolution studies of praziquantel.
Analytical method validation Linearity and Range
The linearity was verified qualitatively by running the plot; at several concentrations anon, plot was observed that amplitudes gradually changed (increased) at 286 nm ( Fig.4) , this was prime face evidence on the suitability of the method for analysis. The linearity was assessed by the regression equation of calibration curve further the data and regression equation of calibration curves were proclaimed in Table 1 and Fig.5 , denotes responses for praziquantel at 286 nm were found to be linear in the concentration range of 1-20 μg/mL, with a correlation co-efficient (R 2 ) value of 0.996.
Selectivity
Fluorescence spectrum attained from the commercial formulation solution was compared with the spectrum of standard solution (praziquantel). Both commercial formulation spectrum and the standard solutions spectrum were superimposed; u n c o r r e c t e d p r o o f denoted no interference from excipients with response of praziquantel at analytical wavelength286 nm. Hence the method was found to be specific and selective.
Accuracy (Recovery studies)
The accuracy was assessed by standard addition method at three distinct levels (80%, 100% and 120%) of standards coalesced to commercial tablets in triplicate anon the mean of percentage recoveries, % RSD values was computed and proclaimed in Table   2 . The % RSD values at relevant concentration level was 2 and % recoveries of praziquantel were assessed to be in the range of 99 -101 and thus suggesting the accuracy of the method [18] .
Precision
Intra-day and inter-day precision harmony was appraised as per ICH guidelines, in which samples containing praziquantel (5/10 and 15µg/mL) were analyzed six times on the same day (intra-day precision) and for three consecutive days (inter-day precision), anon % RSD was calculated. Results of intra-day and inter-day precision data were proclaimed in Table 3 , it revealed that there was no significant distinction between the % RSD values of intra-day and inter-day analysis, which indicates the contemplated method, is highly precise.
Limit of detection (LOD) and limit of quantitation (LOQ)
Limit of detection (LOD) and Limit of quantification (LOQ) parameters were discretely appraised based on standard calibration curve, results proclaimed in Table 1 .
Applications Assay
The contemplated method was employed to the assay of commercial tablets (Zenticide®), containing praziquantel (600 mg). The results were correlated with consequent labelled amounts and proclaimed in Table 4 , best peaks of the assay in tablets found to be 100.1(% RSD < 2), which indicates the accuracy of the proposed method. 
In-vitro dissolution testing
Dissolution studies on praziquantel tablets were enforced under the FDA dissolution test medium as USP dissolution apparatus type 2 containing 900 mL of 0.1 M HCl with 2.0 mg of sodium lauryl sulphate as dissolution medium at a paddle speed of 50 rpm at temperature 37 ± 0.5  C. These results and profiles were proclaimed in Fig6, revealed that amplified than 95% of praziquantel was dissolved from the tablet dosage form.
Forced degradation studies
The stability of praziquantel was studied to elucidate the inherent stability characteristics of it in terms of fluorescence intensity in the incidence of acid/alkali hydrolysis, oxidative, thermal and UV light, anon counter the plot between % drug degraded Vs time interval. The degradation was observed in 5M HCl (81 % up to 60 min) and 5MNaoH (1.0 % up to 60 min) and 1% H2O2 (84% up to 60 min) but there was no evidence of degradation under UV light and thermal conditions (data not shown). The acidic and oxidative degradation was observed that relative fluorescence intensity decreased gradually with increased heating time (Fig 7) . Countered the plot between logarithmic concentration against time shown in Figures 8 & 9 and calculated the half-life and first order rate constants for acid and oxidative degradation ( Table 5 ).
CONCLUSION
The contemplated spectrofluorimetric method has the advantages of being economical, simple, sensitive, specific and extraction free for quantification of praziquantel in tablets and in-vitro dissolution samples. Furthermore, the work was also 
